Fish oil-based lipid emulsions in the treatment of parenteral nutrition-associated liver disease: An ongoing positive experience

Advances in Nutrition

Volumn 5, Issue 1, 2014, Pages 65-70

  Premkumar, Muralidhar H ^a   Carter, Beth A ^b   Hawthorne, Keli M ^a   King, Kristi ^b   Abrams, Steven A ^a  

^a Division of Neonatology   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FISH OIL; LIPID EMULSION; OMEGAVEN; PHOSPHOLIPID; SOYBEAN OIL; SOYBEAN OIL, PHOSPHOLIPID EMULSION;

COMPASSIONATE USE; EMULSION; EXTREMELY LOW BIRTH WEIGHT; FEMALE; HOSPITAL; HUMAN; INFANT; INTRAHEPATIC CHOLESTASIS; MALE; NEWBORN; OBSERVATIONAL STUDY; ORGANIZATION; PATHOPHYSIOLOGY; PREMATURITY; REVIEW; SEVERITY OF ILLNESS INDEX; TOTAL PARENTERAL NUTRITION; UNITED STATES;

CHOLESTASIS, INTRAHEPATIC; COMPASSIONATE USE TRIALS; CONGRESSES AS TOPIC; EMULSIONS; FAT EMULSIONS, INTRAVENOUS; FEMALE; FISH OILS; HOSPITALS, PEDIATRIC; HUMANS; INFANT; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, EXTREMELY PREMATURE; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; MALE; OBSERVATIONAL STUDY AS TOPIC; PARENTERAL NUTRITION, TOTAL; PHOSPHOLIPIDS; SEVERITY OF ILLNESS INDEX; SOYBEAN OIL; TEXAS;

EID: 84907166639     PISSN: 21618313     EISSN: 21565376     Source Type: Journal    
DOI: 10.3945/an.113.004671     Document Type: Article

References (28)

1. Beath SV, Davies P, Papadopoulou A, Khan AR, Buick RG, Corkery JJ, Gornall P, Booth IW. Parenteral nutrition-related cholestasis in postsurgical neonates: multivariate analysis of risk factors. J Pediatr Surg. 1996;31:604-6.
2. Carter BA, Karpen SJ. Intestinal failure-associated liver disease: management and treatment strategies past, present, and future. Semin Liver Dis. 2007;27:251-8.
3. Willis TC, Carter BA, Rogers SP, Hawthorne KM, Hicks PD, Abrams SA. High rates of mortality and morbidity occur in infants with parenteral nutrition-associated cholestasis. JPEN J Parenter Enteral Nutr. 2010;34:32-7.
4. Schuberth O. [Parenteral nutrition with amino acids]. Nutr Dieta Eur Rev Nutr Diet. 1961;3 Suppl:41-51.
5. Rager R, Finegold MJ. Cholestasis in immature newborn infants: is parenteral alimentation responsible? J Pediatr. 1975;86:264-9.
6. Squires RH, Duggan C, Teitelbaum DH, Wales PW, Balint J, Venick R, Rhee S, Sudan D, Mercer D, Martinez JA, et al. Natural history of pediatric intestinal failure: initial report from the Pediatric Intestinal Failure Consortium. J Pediatr. 2012;161:723-8.e2
7. Carter BA, Shulman RJ. Mechanisms of disease: update on the molecular etiology and fundamentals of parenteral nutrition associated cholestasis. Nat Clin Pract Gastroenterol Hepatol. 2007;4:277-87.
8. Carter BA, Taylor OA, Prendergast DR, Zimmerman TL, Von Furstenberg R, Moore DD, Karpen SJ. Stigmasterol, a soy lipid-derived phytosterol, is an antagonist of the bile acid nuclear receptor FXR. Pediatr Res. 2007;62:301-6.
9. Clayton PT, Whitfield P, Iyer K. The role of phytosterols in the pathogenesis of liver complications of pediatric parenteral nutrition. Nutrition. 1998;14:158-64.
10. Javid PJ, Greene AK, Garza J, Gura K, Alwayn IP, Voss S, Nose V, Satchi-Fainaro R, Zausche B, Mulkern RV, et al. The route of lipid administration affects parenteral nutrition-induced hepatic steatosis in a mouse model. J Pediatr Surg. 2005;40:1446-53.
11. Mayer K, Fegbeutel C, Hattar K, Sibelius U, Kramer HJ, Heuer KU, Temmesfeld-Wollbruck B, Gokorsch S, Grimminger F, Seeger W. Omega-3 vs. omega-6 lipid emulsions exert differential influence on neutrophils in septic shock patients: impact on plasma fatty acids and lipid mediator generation. Intensive Care Med. 2003;29:1472-81.
12. Meisel JA, Le HD, de Meijer VE, Nose V, Gura KM, Mulkern RV, Akhavan Sharif MR, Puder M. Comparison of 5 intravenous lipid emulsions and their effects on hepatic steatosis in a murine model. J Pediatr Surg. 2011;46:666-73.
13. de Meijer VE, Gura KM, Meisel JA, Le HD, Puder M. Parenteral fish oil monotherapy in the management of patients with parenteral nutritionassociated liver disease. Arch Surg. 2010;145:547-51.
14. Gura KM, Duggan CP, Collier SB, Jennings RW, Folkman J, Bistrian BR, Puder M. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics. 2006;118:e197-201.
15. Gura KM, Parsons SK, Bechard LJ, Henderson T, DorseyM, Phipatanakul W, Duggan C, Puder M, Lenders C. Use of a fish oil-based lipid emulsion to treat essential fatty acid deficiency in a soy allergic patient receiving parenteral nutrition. Clin Nutr. 2005;24:839-47.
16. Le HD, de Meijer VE, Zurakowski D, Meisel JA, Gura KM, Puder M. Parenteral fish oil as monotherapy improves lipid profiles in children with parenteral nutrition-associated liver disease. JPEN J Parenter Enteral Nutr. 2010;34:477-84.
17. Premkumar MH, Carter BA, Hawthorne KM, King K, Abrams SA. High rates of resolution of cholestasis in parenteral nutrition-associated liver disease with fish oil-based lipid emulsion monotherapy. J Pediatr, 2013. 162:793-8.e1.
18. Puder M, Valim C, Meisel JA, Le HD, de Meijer VE, Robinson EM, Zhou J, Duggan C, Gura KM. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg. 2009;250:395-402.
19. Dicken BJ, Huynh HQ, Turner JM. More evidence on the use of parenteral omega-3 lipids in pediatric intestinal failure. J Pediatr. 2011;159: 170-1.
20. Fallon EM, Le HD, PuderM. Prevention of parenteral nutrition-associated liver disease: role of omega-3 fish oil. Curr Opin Organ Transplant. 2010; 15:334-40.
21. Novak TE, Babcock TA, Jho DH, Helton WS, Espat NJ. NF-kappa B. inhibition by omega-3 fatty acids modulates LPS-stimulated macrophage TNF-alpha transcription. Am J Physiol Lung Cell Mol Physiol. 2003; 284:L84-9.
22. Wang X, Li W, Li N, Li J. Omega-3 fatty acids-supplemented parenteral nutrition decreases hyperinflammatory response and attenuates systemic disease sequelae in severe acute pancreatitis: a randomized and controlled study. JPEN J Parenter Enteral Nutr. 2008;32:236-41.
23. Slagle TA, Gross SJ. Effect of early low-volume enteral substrate on subsequent feeding tolerance in very low birth weight infants. J Pediatr. 1988;113:526-31.
24. Dicken BJ, Sergi C, Rescorla FJ, Breckler F, Sigalet D. Medical management of motility disorders in patients with intestinal failure: a focus on necrotizing enterocolitis, gastroschisis, and intestinal atresia. J Pediatr Surg. 2011;46:1618-30.
25. Sigalet D, Boctor D, Brindle M, Lam V, Robertson M. Elements of successful intestinal rehabilitation. J Pediatr Surg. 2011;46:150-6.
26. Diamond IR, de Silva N, Pencharz PB, Kim JH, Wales PW. Group for the Improvement of Intestinal, and Treatment. Neonatal short bowel syndrome outcomes after the establishment of the first Canadian multidisciplinary intestinal rehabilitation program: preliminary experience. J Pediatr Surg. 2007;42:806-11.
27. Nehra D, Fallon EM, Potemkin AK, Voss SD, Mitchell PD, Valim C, Belfort MB, Bellinger DC, Duggan C, Gura KM, et al. A comparison of 2 intravenous lipid emulsions: interim analysis of a randomized controlled trial. JPEN J Parenter Enteral Nutr. Epub 2013 Jun 13.
28. Holman RT, Smythe L, Johnson S. Effect of sex and age on fatty acid composition of human serum lipids. Am J Clin Nutr. 1979;32:2390-9.